Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology

Published on Feb 16, 2021in Lancet Infectious Diseases24.446
· DOI :10.1016/S1473-3099(20)30784-2
Martin Hoenigl42
Estimated H-index: 42
,
Jon Salmanton-García7
Estimated H-index: 7
(University of Cologne)
+ 42 AuthorsOliver A. Cornely91
Estimated H-index: 91
Sources
Abstract
Summary With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Aspergillus spp or Mucorales are increasing. Although antifungal prophylaxis has shown effectiveness in preventing many invasive fungal infections, selective pressure has caused an increase of breakthrough infections caused by Fusarium, Lomentospora, and Scedosporium species, as well as by dematiaceous moulds, Rasamsonia, Schizophyllum, Scopulariopsis, Paecilomyces, Penicillium, Talaromyces and Purpureocillium species. Guidance on the complex multidisciplinary management of infections caused by these pathogens has the potential to improve prognosis. Management routes depend on the availability of diagnostic and therapeutic options. The present recommendations are part of the One World—One Guideline initiative to incorporate regional differences in the epidemiology and management of rare mould infections. Experts from 24 countries contributed their knowledge and analysed published evidence on the diagnosis and treatment of rare mould infections. This consensus document intends to provide practical guidance in clinical decision making by engaging physicians and scientists involved in various aspects of clinical management. Moreover, we identify areas of uncertainty and constraints in optimising this management.
References74
Newest
#1Jon Salmanton-García (University of Cologne)H-Index: 7
#2Philipp Koehler (University of Cologne)H-Index: 18
Last. Jin YuH-Index: 1
view all 82 authors...
Abstract Objectives Emerging invasive fungal infections (IFI) have become a notable challenge. Apart from the more frequently described fusariosis, lomentosporiosis, mucormycosis, scedosporiosis, and certain dematiaceae or yeasts, little is known about extremely rare IFI. Methods Extremely rare IFI collected in the FungiScope® registry were grouped as Dematiaceae, Hypocreales, Saccharomycetales, Eurotiales, Dermatomycetes, Agaricales, and Mucorales. Results Between 2003 and June 2019, 186 extrem...
8 CitationsSource
#1Martin Hoenigl (UCSD: University of California, San Diego)H-Index: 42
33 CitationsSource
#1Jeffrey D Jenks (UCSD: University of California, San Diego)H-Index: 13
#2Juergen Prattes (Medical University of Graz)H-Index: 19
Last. Martin Hoenigl (UCSD: University of California, San Diego)H-Index: 42
view all 8 authors...
BACKGROUND The Aspergillus Galactomannan Lateral Flow Assay (LFA) is a rapid test for the diagnosis of invasive aspergillosis (IA) that has been almost exclusively evaluated in patients with hematologic malignancies. An automated digital cube reader which allows for quantification of results has recently been added to the test kits. METHODS We performed a retrospective multicenter study on bronchoalveolar lavage fluid (BALF) samples obtained from 296 patients with various underlying diseases (65...
19 CitationsSource
16 CitationsSource
#1Jeffrey D Jenks (UCSD: University of California, San Diego)H-Index: 13
#2Danila SeidelH-Index: 21
Last. Martin Hoenigl (UCSD: University of California, San Diego)H-Index: 42
view all 26 authors...
Abstract Objectives Lomentospora prolificans is an emerging cause of serious invasive fungal infections. Optimal treatment of these infections is unknown, although voriconazole-containing treatment regimens are considered the treatment of choice. The objective of this study was to evaluate the role of combination antifungal therapy for L. prolificans infections. Methods We performed a retrospective review of medical records of patients with invasive L. prolificans infection diagnosed between 01/...
22 CitationsSource
#1Amir ArastehfarH-Index: 14
#2Agostinho Carvalho (University of Minho)H-Index: 33
Last. Martin Hoenigl (UCSD: University of California, San Diego)H-Index: 42
view all 10 authors...
Like severe influenza, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome (ARDS) has emerged as an important disease that predisposes patients to secondary pulmonary aspergillosis, with 35 cases of COVID-19 associated pulmonary aspergillosis (CAPA) published until June 2020 The release of danger-associated molecular patterns during severe COVID-19 results in both pulmonary epithelial damage and inflammatory disease, which are predisposing risk factors for pulmonar...
95 CitationsSource
#1Jeffrey D Jenks (UCSD: University of California, San Diego)H-Index: 13
#2Danila SeidelH-Index: 21
Last. Martin Hoenigl (UCSD: University of California, San Diego)H-Index: 42
view all 20 authors...
OBJECTIVES: Invasive fungal infections caused by Lomentospora prolificans are associated with very high mortality rates and can be challenging to treat given pan-drug resistance to available antifungal agents. The objective of this study was to describe the clinical presentation and outcomes in a cohort of patients with invasive L. prolificans infections. METHODS: We performed a retrospective review of medical records of patients with invasive L. prolificans infection in the FungiScope(R) regist...
11 CitationsSource
#1Jannik Stemler (University of Cologne)H-Index: 4
#2Jon Salmanton-García (University of Cologne)H-Index: 7
Last. Oliver A. CornelyH-Index: 91
view all 14 authors...
BACKGROUND: The new Rasamsonia spp. complex can develop invasive infection in immunosuppression or chronic pulmonary disease. It has potential to be misidentified as other genera due to morphological similarities. Nowadays, there is a gap of knowledge on this fungi. OBJECTIVES: To provide knowledge base of risk factors and therapeutic decisions in invasive Rasamsonia spp. complex infection. PATIENTS/METHODS: Cases of invasive infection due to Rasamsonia spp. (formerly Geosmithia/Penicillium spp....
9 CitationsSource
#1Danila Seidel (University of Cologne)H-Index: 21
#2Angela Hassler (Goethe University Frankfurt)H-Index: 7
Last. Thomas Lehrnbecher (Goethe University Frankfurt)H-Index: 54
view all 18 authors...
Abstract Objectives Current knowledge on infections caused by Scedosporium spp. and Lomentospora prolificans in children is scarce. We therefore aim to provide an overview of risk groups, clinical manifestation and treatment strategies of these infections. Methods Pediatric patients (age ≤18 years) with proven/probable Scedosporium spp. or L. prolificans infection were identified in PubMed and the FungiScope® registry. Data on diagnosis, treatment and outcome was collected. Results Fifty-five ch...
6 CitationsSource
#1Oliver A. CornelyH-Index: 91
#2Ana Alastruey-Izquierdo (ISCIII: Carlos III Health Institute)H-Index: 37
Last. Arunaloke ChakrabartiH-Index: 66
view all 74 authors...
Summary Mucormycosis is a difficult to diagnose rare disease with high morbidity and mortality. Diagnosis is often delayed, and disease tends to progress rapidly. Urgent surgical and medical intervention is lifesaving. Guidance on the complex multidisciplinary management has potential to improve prognosis, but approaches differ between health-care settings. From January, 2018, authors from 33 countries in all United Nations regions analysed the published evidence on mucormycosis management and p...
240 CitationsSource
Cited By20
Newest
#1Marcio NucciH-Index: 65
#2Gloria BarreirosH-Index: 9
Last. Simone A. NouérH-Index: 19
view all 5 authors...
Fusarium species are filamentous fungi widely encountered in nature, and may cause invasive disease in patients with hematologic conditions. Patients at higher risk are those with acute leukemia receiving induction remission chemotherapy or allogeneic hematopoietic cell transplant recipients. In these hosts, invasive fusariosis presents typically with disseminated disease, fever, metastatic skin lesions, pneumonia, and positive blood cultures. The prognosis is poor and the outcome is largely dep...
Source
Fungal infections have been increasing during the last decades. Scedosporium and Lomentospora species are filamentous fungi most associated to those infections, especially in immunocompromised patients. Considering the limited options of treatment and the emergence of resistant isolates, an increasing concern motivates the development of new therapeutic alternatives. In this context, the present study screened the Pathogen Box library to identify compounds with antifungal activity against Scedos...
Source
#1Jannik Stemler (University of Cologne)H-Index: 4
#2Michaela Lackner (Innsbruck Medical University)H-Index: 31
Last. Oliver A. CornelyH-Index: 91
view all 5 authors...
Background null Invasive scedosporiosis and lomentosporiosis are life-threatening fungal infections in immunocompromised patients with complex diagnostic and treatment patterns. null Objectives null To develop a scoring tool to facilitate and quantify adherence to current guideline recommendations for diagnosis, treatment and follow-up of invasive scedosporiosis and lomentosporiosis. null Methods null Experts from European Confederation of Medical Mycology (ECMM) excellence centres reviewed curr...
Source
#1P. HamalH-Index: 143
#2Anna Vavrova (Palacký University, Olomouc)
Last. Lucie SvobodováH-Index: 4
view all 4 authors...
Identification of filamentous fungi based on morphological features is the most available approach used in clinical mycology laboratories. However, MALDI-TOF mass spectrometry is currently invaluable for identification of microorganisms because of its rapidity, simplicity, and accuracy. This study aimed to find the optimal way of identifying filamentous fungi using MALDI-TOF MS.The sample comprised 193 isolates of filamentous fungi. The identification started with morphological assessment. Then ...
Source
#1Amelie P Brackin (Imperial College London)H-Index: 2
#2Sam J Hemmings (Imperial College London)H-Index: 1
Last. Johanna Rhodes (Imperial College London)H-Index: 18
view all 4 authors...
Respiratory infections caused by fungal pathogens present a growing global health concern and are a major cause of death in immunocompromised patients. Worryingly, coronavirus disease-19 (COVID-19) resulting in acute respiratory distress syndrome has been shown to predispose some patients to airborne fungal co-infections. These include secondary pulmonary aspergillosis and mucormycosis. Aspergillosis is most commonly caused by the fungal pathogen Aspergillus fumigatus and primarily treated using...
1 CitationsSource
#1Mohammad Javad Najafzadeh (MUMS: Mashhad University of Medical Sciences)H-Index: 30
#2Somayeh Dolatabadi (HSU: Hakim Sabzevari University)
Last. Jacques F. Meis (UFPR: Federal University of Paraná)H-Index: 103
view all 5 authors...
Background null Exophiala is the main genus of black fungi comprising numerous opportunistic species. Data on antifungal susceptibility of Exophiala isolates are limited, while infections are potentially fatal. null Materials and methods null In vitro activities of eight antifungal drugs (AMB, five azoles, two echinocandins) against 126 clinical (n = 76) and environmental (n = 47) isolates from around the world were investigated. E. oligosperma (n = 58), E. spinifera (n = 33), E. jeanselmei (n =...
Source
#1Karl Dichtl (LMU: Ludwig Maximilian University of Munich)H-Index: 6
#2Özlem Koc (LMU: Ludwig Maximilian University of Munich)
Last. Ines SchroederH-Index: 6
view all 8 authors...
Background null Increasing incidence of invasive infections caused by rare fungi was observed over the recent years. null Case null Here, we describe the first reported case of an infection caused by the thermophilic mold Talaromyces thermophilus. Cultivation and, hence, identification of this fastidious organism is challenging since standard incubation conditions are not sufficient. Retrospective analysis of patient samples and in vitro experiments demonstrated that testing for fungal antigens,...
Source
#1Daniel S. Krauth (NMCSD: Naval Medical Center San Diego)
#2Brian T. Barlow (USU: Uniformed Services University of the Health Sciences)
Last. Catherine M. Berjohn (NMCSD: Naval Medical Center San Diego)
view all 3 authors...
Abstract null null Invasive osteoarticular infections (IOI) due to Scedosporium spp. are rare in the immune competent patient, but have been associated with direct inoculation from antecedent trauma. Here we describe a case of IOI due to Scedosporium dehoogii in a previously healthy man. The clinical presentation and the diagnosis and treatment is discussed. To our knowledge, this is the first reported case of IOI caused by S. dehoogii.
Source
#1Amy Spallone (BCM: Baylor College of Medicine)H-Index: 1
#2Ilan S. Schwartz (U of A: University of Alberta)H-Index: 17
Various uncommon fungal pathogens have been increasingly identified as causes of disseminated and invasive fungal disease (IFD) worldwide. Growing recognition and clinical knowledge of these emerging fungal pathogens has occurred through improved molecular diagnostics, nucleic sequence databases, and taxonomic reclassification of medically significant fungi. However, emerging fungal diseases carry significant morbidity and mortality and, due to a paucity of published literature, the collective c...
1 CitationsSource
#1Andreas H. Groll (Boston Children's Hospital)H-Index: 72
#2Dorothea Pana (UCY: University of Cyprus)H-Index: 1
Last. Thomas Lehrnbecher (Goethe University Frankfurt)H-Index: 54
view all 16 authors...
Summary Paediatric patients with cancer and those undergoing allogeneic haematopoietic cell transplantation have an increased susceptibility to invasive fungal diseases. In addition to differences in underlying conditions and comorbidities relative to adults, invasive fungal diseases in infants, children, and adolescents are unique in terms of their epidemiology, the validity of current diagnostic methods, the pharmacology and dosing of antifungal agents, and the absence of phase 3 clinical tria...
7 CitationsSource